-
-
-
-
-
-
-
Maxim Group Downgrades Brainstorm Cell Therapeutics (BCLI) to Hold
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn in ALS
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Files for 16.67M Share Offering by Selling Stockholders
-
-
-
-
436,161 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

